Sagnik Bhattacharyya

King’s College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

Marco Colizzi

University of Udine

ITALY

View details

K Ray Chaudhuri

King’s College London

UNITED KINGDOM

View details

Fernando Zelaya

King’s College London

UNITED KINGDOM

View details

Jorn Lotsch

Professor (Full)

Goethe University Frankfurt

GERMANY

View details

Charlotte Pretzsch

King’s College London

UNITED KINGDOM

View details

Daniel Martins

King’s College London

UNITED KINGDOM

View details

Latha Velayudhan

King’s College London

UNITED KINGDOM

View details

Alison Yung

The University of Manchester

UNITED KINGDOM

View details

robin murray

King’s College London

UNITED KINGDOM

View details

Dominic ffytche

King’s College London

UNITED KINGDOM

View details

Paul Allen

UNITED KINGDOM

View details

Sara Pisani

King's College London

UNITED KINGDOM

View details

David Lythgoe

King’s College London

UNITED KINGDOM

View details

Dag Aarsland

King’s College London

UNITED KINGDOM

View details

Mattia Veronese

King’s College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sagnik Bhattacharyya

Research Interests

Explore related searches

Contact this professor

Articles (19)

Cannabidiol as a treatment for patients who are clinically at high risk of developing psychosis: learnings from the CANTOP-RCT

Parkinson’s disease psychosis associated with accelerated multidomain cognitive decline

A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: An umbrella review of systematic reviews and meta-analyses

Cannabidiol for behavior symptoms in Alzheimer's disease (CANBiS-AD)

Adverse events caused by cannabinoids in middle aged and older adults for all indications

Effects of cannabidiol on symptoms in people at clinical high risk for psychosis

Functional and connectivity correlates associated with Parkinson's disease psychosis

Cognitive and executive impairments in Parkinson’s disease psychosis: a Bayesian meta-analysis

Biobehavioral Interactions between Endocannabinoid and Hypothalamic-pituitary-adrenal Systems in Psychosis

Cannabidiol attenuates insular activity during motivational salience processing in patients with early psychosis

Stressful life events and relapse of psychosis

Grey matter volume loss in Parkinson’s Disease Psychosis and its relationship with serotonergic gene expression: A meta-analysis

Association between stressful life events and psychosis relapse

Questioning the role of palmitoylethanolamide in psychosis

Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk

Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol

Task-independent acute effects of delta-9-tetrahydrocannabinol on human brain function and its relationship with cannabinoid receptor gene expression

Cannabinoids in psychiatry

The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System

Collaborators (15)

Marco Colizzi

K Ray Chaudhuri

Fernando Zelaya

Jorn Lotsch

Charlotte Pretzsch

Daniel Martins

Latha Velayudhan

Alison Yung

robin murray

Dominic ffytche

Paul Allen

Sara Pisani

David Lythgoe

Dag Aarsland

Mattia Veronese

Make your next move.